0 items USD 0.00Search
Your search for "current partnering global antibody partnering 2010 2015 deal trends players financials" gave back 48391 results.
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
Catalog:
La Merie Publishing
May 2020
Price: USD 2,350.00
“Lutetium-177 Global Market Analysis” gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The “COVID-19 Neutralizing Antibody Drugs Industry Forecast” looks at past sales and reviews total world COVID-19 Neutralizing Antibody Drugs sales...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Highlights The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
Catalog:
AEI
June 2021
Price: USD 3,000.00
The “B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Forecast” looks at past sales and reviews total world B-Cell Maturation Antigen (...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market size was valued at US$ million in 2023. With growing demand in downstream...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global B-Cell Maturation Antigen (BCMA) Targeted Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
